A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 232
Summary
- Conditions
- Advanced Solid Tumor
- Gynecologic Cancer
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04042116
- Collaborators
- Bristol-Myers Squibb
- European Network of Gynaecological Oncological Trial Groups (ENGOT)
- Investigators
- Principal Investigator: Erika Hamilton, MD Tennessee Oncology, PLLC Principal Investigator: Nicole Concin, MD KEM Kliniken Essen Mitte Evang. Huyssens-Stiftung
Get Well Soon